UDPDglucuronic

UDP‑glucuronic acid (UDP‑GlcUA) is a nucleotide sugar that functions as a universal uronic acid donor in the synthesis of complex carbohydrates and in the conjugation of xenobiotics. It consists of uridine monophosphate linked to glucuronic acid and is a key intermediate in the metabolic pathway that generates glucuronic acid from glucose.

UDP‑GlcUA is produced by the enzyme UDP‑glucose 6‑dehydrogenase (UGDH) which oxidizes UDP‑glucose to UDP‑glucuronic acid. The reaction requires NAD⁺ as a cofactor and the enzyme localizes primarily in the cytosol, with significant activity in liver and kidney tissues. The equilibrium of UDP‑glucose and UDP‑glucuronic acid is maintained by reversible reactions that allow the cell to respond to changes in glucuronic acid demand.

This nucleotide sugar serves as the donor substrate for UDP‑glucuronosyltransferases (UGTs), a family of enzymes that attach glucuronic acid to a variety of endogenous and exogenous molecules. Conjugation with glucuronic acid increases solubility, facilitating excretion of bilirubin, steroid hormones, drugs, and environmental toxins through bile or urine. Beyond detoxification, UDP‑glucuronic acid is essential for the biosynthesis of glycosaminoglycans (such as hyaluronic acid and chondroitin sulfate) and for the production of certain glycolipids and cell surface glycoconjugates that play roles in cell signalling and pathogen recognition.

Abnormalities in UDP‑glucuronosyltransferase activity or UDP‑glucuronic acid production can lead to clinical disorders, including impaired bilirubin conjugation (conjugated hyperbilirubinemia) and altered drug metabolism. Genetic variants in UGT genes and promoter variants influencing UGDH expression are among the contributing factors. Consequently, UDP‑glucuronic acid remains a focal point in studies of hepatic clearance, metabolic regulation, and therapeutic drug development.